valve replacement in infective endocarditis pja slabbert cardiology
TRANSCRIPT
![Page 1: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/1.jpg)
Valve Replacement in Infective Endocarditis
PJA SlabbertCardiology
![Page 2: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/2.jpg)
Patient history
34 year male from NCAdmitted KHC : 23/3/10 to 8/4/10 for Infective Endocarditis (culture negative) Pen G and Gentamycin
Clinically deteriorated over 3 days and follow up echocardiogram showed: Worsening heart failure More extensive vegetations on aorta
valves
![Page 3: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/3.jpg)
Systemic enquiry: Neurology: no TIA, no amurosis fugax Respiratory: 3 weeks non productive cough,
progressive dyspnoea Cardiology: Angina on exertion, ortopnea,
PND, dyspnoea NYHA grade 4, ankle swelling, no sharp chest pain radiating to back.
Gastro-enterology: vomited previous night.
Previous medical Hx: D-E-A-T-H-, not known with cardiac condition,
no chronic medication
![Page 4: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/4.jpg)
ExaminationGeneral: Chronically ill: underweight J-A-C-C-O+L- BP 121/52 (no cardiogenic shock, wide pulse
pressure), HR 92/m, normal temperature, RR 33/m, saturation 98% on 40% oxygen
Diffuse fungal/ yeast skin infection: Pityriasis versicolor
No peripheral manifestations of infective endocarditis: Roth spots, subungual hemorrhages, Janeway lesions
![Page 5: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/5.jpg)
Cardiovascular Water hammer pulse, equal pulses and
BP left and right. Elevated JVP 2cm above baseline
Apex displaced inferior lateral: 6th ics aal
Loud P2, C3 both ventricles Decrescendo diastolic murmur
parasternally with ejection systolic murmur not radiating. No Austin Flint
![Page 6: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/6.jpg)
Respiratory: Diffuse inspiratory crackles Distressed : tachypnoea, accessory
muscle use.
Abdomen: No Hepatomegaly, No splenomegaly
Urine Dipstix : no microscopic hematuria
![Page 7: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/7.jpg)
Problem List
Infective EndocarditisSevere Aorta Regurgitation with signs of bi-ventricular failurePulmonary edema with acute respiratory failure
![Page 8: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/8.jpg)
Special investigationBloods: FBC : WCC 8.4, Hb 14.1, plt 191 U&E : Na 136, K 5.2, Urea 17.6, Cr 133 LFT : t-prot 72, alb 25, t-Billi 35, c-Billi 16, ALP
109, GGT 108, AST 165, ALT 293, LDH 150 CRP 5.2 Trop-T : negative, CK : normal ASOT negative, ANA negative, RF negative,
RPR negative, HIV negative BC negative
Cardiac echo CXR ECG
![Page 9: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/9.jpg)
ECG
![Page 10: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/10.jpg)
CXR
![Page 11: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/11.jpg)
echoAorta root diameter = 30 mm (normal)Aorta valve opening = 21 mm (normal)Vegetation on all three aorta cuspsPressure half time = 67 ms (<200ms severe acute AR)Mitral valve : mild regurgitationLeft Atrium : 4.3 cm (enlarged)Left ventricle: LVEDD 6.5 cm, LVESD 5 cm, LVEF = 44%Right heart mildly enlarged, mild TI, RVPSP = 65 mmHg
![Page 12: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/12.jpg)
![Page 13: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/13.jpg)
Treatment
Furosemide 40 mg bd iviEnalapril 5 mg bd poElantin 20 mg bd poPen G, Gentamycin, Cloxacillin, DiflucanUrgent cardio-thoracic consult Ross procedure was done
![Page 14: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/14.jpg)
Surgery in NVE
Introduction 1961 : Kay and colleagues excised fungal
vegetation from tricuspid valve 1965 : AVR in IE due to Serratia Marcescens Last 3 decades : valve replacement/ repair
common in Mx of complicated IE Decreased mortality in IE due to
combination of antibiotics and timely surgical intervention
![Page 15: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/15.jpg)
Indications
2006 American College of Cardiology/ American Heart Association (ACC/ AHA) Surgery is warranted for native valve IE who
have one or more of the following 1. Heart failure (moderate to severe) that is directly
related to valve dysfunction. 2. Severe aorta/ mitral regurgitation with evidence
of abnormal hemodinamics, such as elevated LVED or left atrial pressures.
3. Endocarditis due to fungal of high resistant organisms.
4. Peri-valvular infection with abscess/ fistula formation
![Page 16: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/16.jpg)
Other condition considered as possible indications 1. Embolic events while on
appropriate antibiotic regimen or large vegetations (> 10mm in diameter)
2. Large vegetations > 10mm in diameter (even without embolic events) if mobile
![Page 17: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/17.jpg)
Choice of procedure
For active infection (2006 ACC/AHA): Valve repair rather than replacement
Only possible in minority of cases Thus leaflet perforation without
destruction or annular involvement.
![Page 18: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/18.jpg)
Heart Failure
Moderate to severe HF due to IE Medical therapy : mortality rate 75% Medical & surgical : mortality rate 25%
HF is indication in 2/3 to ¾ of casesIE induced AR is more likely to produce HF than IE induced MR (death may occur suddenly in aorta involvement)
![Page 19: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/19.jpg)
Caveats Non cardiac factors that exaggerate HF
Fever, anemia, sepsis, renal insufficiency Hx of previous HF.
HF out of proportion to valve dysfunction.
![Page 20: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/20.jpg)
Complicated infection
Persistent positive BC 5 to 7 days or lack of clinical improvement
after 1 week of appropriate Rx search for metastatic abscess; then
Echocardiographic evidence of perivalvular abcess / fistula formation/ leaflet perforation Serial TEE and early in presence of known
difficult organism.
New heart block
![Page 21: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/21.jpg)
Fungal infection is in general an early indication for Relapse after adequate therapy may require intervention. A 2nd course of antibiotics is only indicated if no perivalvular infection and offending organism is sensitive to Rx.
![Page 22: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/22.jpg)
Embolization
Overall risk : 13 – 44%Decline after effective antimicrobial Rx, thus not necessary to prevent stroke. indicated after a second embolic event after appropriate Rx in patient with persistent vegetations.‘Silent’ emboli, thus screen (CT scan) all patient with large (>1cm) or mobile vegetations prior to
![Page 23: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/23.jpg)
Emboli ( risk)
Cardiopulmonary bypass and need for anticoagulation increases the risk of extending infarct and or converting a nonhemorrhagic infarct into a hemorrhagic lesion.Suggested is postponed 2 weeks after cerebral infarction and 4 weeks after cerebral hemorrhage. May be done before 2 weeks if compelling indications (eg moderate HF).
![Page 24: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/24.jpg)
Emboli (vegetation size)
Larger size larger risk for emboliIn general is not indicated for increase in vegetation size in patient responding well to medical RxVegetations > 10mm by itself is not sufficient to require , unless other complicating features.
![Page 25: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/25.jpg)
Timing of surgery
Concern: placing prosthetic valve in actively infected tissue !Recommendation: should not be delayed with clear indications regardless of duration of pre-operative antibiotics.
![Page 26: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/26.jpg)
Antibiotic following surgery
2004 European Society of Cardiology (ESC): Full course of antibiotic Rx if valve
culture is positive If culture negative, complete full
course counting the pre-operative duration of Rx. Minimum duration 7 to 15 days post operative. Rate of relapse 3/358
![Page 27: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/27.jpg)
Reference
Fauci, AS, Braunwald, E, Harrison’s Principles of Internal Medicine, 17th Edition, 2008Schick, EC, Surgery for native valve endocarditis, Uptodate, June 2008Talley, NJ, O’Conner, S, Clinical examination, 2001
![Page 28: Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology](https://reader035.vdocuments.net/reader035/viewer/2022062303/5519c82c550346695e8b49a1/html5/thumbnails/28.jpg)
Q & A
Thank you